Fc Global Realty (FCRE) Stock Price, News & Analysis

Company Overview

FC Global Realty (OTCMKTS: FCRE) is a real estate investment and management company focused on acquiring, developing, and operating a diversified portfolio of commercial and residential properties. The firm provides comprehensive property management services, including leasing, tenant relations, and facility maintenance, alongside real estate development and redevelopment projects. Its offerings also extend to asset management and valuation services, catering to institutional investors, private clients, and corporate tenants seeking stable income streams and long‐term capital appreciation.

Since its inception in 2010, FC Global Realty has pursued a growth strategy centered on value‐added acquisitions in high‐growth markets. Headquartered in Miami, Florida, the company has expanded its footprint across major metropolitan areas in the United States, as well as select markets in Europe and the Asia-Pacific region. Notable investments include mixed‐use residential towers in downtown Atlanta and renovated office campuses in central London, illustrating the firm’s ability to adapt its development expertise to a variety of urban environments and regulatory landscapes.

Underpinning FC Global Realty’s operations is a commitment to sustainable building practices and community engagement. The company has integrated green building standards into its new developments and major renovations, pursuing energy efficiency certifications and promoting environmentally responsible design. In addition, FC Global Realty collaborates with local stakeholders on affordable housing and urban renewal initiatives, seeking to balance financial objectives with broader social impact.

Leadership at FC Global Realty is headed by Chief Executive Officer James Chen, who brings over two decades of experience in real estate finance and development. Chief Financial Officer Mary Clark, a veteran of commercial property underwriting and capital markets, oversees the company’s financial strategy and investor relations. Together, the executive team guides FC Global Realty’s strategic vision, leveraging deep industry expertise to identify market opportunities and drive long‐term growth.

Key Stats

• Today's Range: $0.06 to $0.10
• 50-Day Range: $0.10 to $0.10
• 52-Week Range: $0.03 to $0.56
• Volume: 11,300 shs
• Average Volume: 7,405 shs
• Market Capitalization: $38.87 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FCRE Stock Analysis - Frequently Asked Questions

How have FCRE shares performed this year?

Fc Global Realty's stock was trading at $0.0999 at the beginning of 2025. Since then, FCRE stock has increased by 0.0% and is now trading at $0.0999.

How were Fc Global Realty's earnings last quarter?

Fc Global Realty Inc (OTCMKTS:FCRE) issued its quarterly earnings results on Monday, August, 20th. The medical equipment provider reported $0.08 earnings per share (EPS) for the quarter. The medical equipment provider had revenue of $0.01 million for the quarter. Fc Global Realty had a negative net margin of 4,265.28% and a negative trailing twelve-month return on equity of 24.94%.

When did Fc Global Realty's stock split?

Fc Global Realty shares reverse split on Friday, September 23rd 2016.The 1-5 reverse split was announced on Tuesday, September 13th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 22nd 2016. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

How do I buy shares of Fc Global Realty?

Shares of FCRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Fc Global Realty own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Fc Global Realty investors own include Sophiris Bio (SPHS), (CPXX) (CPXX), Synergy Pharmaceuticals (SGYP), Achieve Life Sciences (ACHV), Cognyte Software (CGNT), Novavax (NVAX) and Pluristem Therapeutics (PSTI).

Company Calendar

• Last Earnings: 8/20/2018
• Today: 7/13/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Electromedical Equipment
• Sub-Industry: Health Care Equipment
• Current Symbol: OTCMKTS:FCRE
• CIK: 711665
• Web: www.gadsdenreit.com
• Phone: 215-813-1430
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.04 million
• Net Margins: -4,265.28%
• Pretax Margin: N/A
• Return on Equity: -24.94%
• Return on Assets: -9.42%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: $40 thousand
• Price / Sales: 971.79
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 389,104,000
• Free Float: N/A
• Market Cap: $38.87 million
• Optionable: Not Optionable
• Beta: 2.31